Description

jwh-018 powder for sale

The authors identified six deaths related to abuse of JWH-018 (postmortem blood levels: 0.11–0.65 ng/mL), six deaths related to abuse of JWH-122, six deaths related to abuse of JWH-210, one each associated with abuse of JWH-175 and JWH-250, respectively. In addition, two fatalities associated with abuse of XLR-11 and nine fatalities associated with abuse of AM-2201 (postmortem blood levels: 0.13–17.0 ng/mL) were also reported [34]. Patton et al. also reported death of a 23-year old man due to AM-2201 overdose. The metabolite of AM-2201 was detected in the postmortem blood [35].

Death due to use of synthetic cannabinoids (S)-methyl-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB), a new synthetic cannabinoid first reported in Japan in early 2014, has also been reported. The concentration of 5F-AMB was only 0.3 ng/mL. However, the authors concluded that the death was accidental [36]. Shanks et al. described a death associated with use of a new synthetic cannabinoid ADB-4-fluorobenzyl-1H-indazole-3-carboxamide (FUBINACA). In this drug, 1-amino-3,3-deimethoxy-1-oxobutane-2yl (ABD) group is linked with FUBINACA base at the amide group. The concentration of this relatively new synthetic cannabinoid in the postmortem blood was 7.3 ng/mL. However, a small amount of THC (1.1 ng/mL) and its metabolite THC-COOH (4.7 ng/mL) was also detected in the postmortem blood using LC-MS/MS [37].